Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8

PURPOSE: The purpose of this study is to test the ability of risedronate and estradiol, alone or in combination, to prevent bone loss associated with androgen deprivation therapy in men with prostate cancer. MATERIALS AND METHODS: This is a randomized placebo-controlled trial of risedronate and estr...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Kearns, Ann E., Northfelt, Donald W., Dueck, Amylou C., Atherton, Pamela J., Dakhil, Shaker R., Rowland, Kendrith M., Fuloria, Jyotsna, Flynn, Patrick J., Dentchev, Todor, Loprinzi, Charles L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3903398/
https://ncbi.nlm.nih.gov/pubmed/19468757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-009-0655-x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items